Oxcarbazepine Tablet, Film Coated
Product Images NDC 0904-7595

8 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 0904-7595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical Structure (Oxcarbazepine 01)
Chemical structure of oxcarbazepine, showing a dibenzazepine core with a ketone and an amide functional group attached to the nitrogen atom.*
FDA Label Image

Figure 1 (Oxcarbazepine 02)

Figure 1 (Oxcarbazepine 02)
A line graph showing exit rates over time from day 2 to day 11 at 8 am comparing two treatment groups: Oxcarbazepine and placebo. The graph includes a log-rank test p-value of 0.0001, indicating statistical comparison between the groups.*
FDA Label Image

Figure 2 (Oxcarbazepine 03)

Figure 2 (Oxcarbazepine 03)
A survival curve chart showing seizure rate over time from first dose to first seizure, comparing two treatment groups: Oxcarbazepine and Placebo. The x-axis represents days from first dose to seizure, and the y-axis represents seizure rate. The chart includes a log-rank test p-value of 0.046 indicating statistical comparison between groups.*
FDA Label Image

Figure 3 (Oxcarbazepine 04)

Figure 3 (Oxcarbazepine 04)
A Kaplan-Meier survival curve chart showing exit rate over time (days) for two treatment groups labeled HIGH and LOW. The y-axis represents exit rate from 0 to 1.0, and the x-axis represents time to exit in days from 0 to 130. The LOW group (dotted line) shows a higher exit rate over time compared to the HIGH group (solid line), with a log-rank test p-value of 0.0001.*
FDA Label Image

Figure 4 (Oxcarbazepine 05)

Figure 4 (Oxcarbazepine 05)
A Kaplan-Meier survival curve graph showing exit rate over time (days) comparing two treatment groups labeled HIGH and LOW. The y-axis represents the exit rate from 0.0 to 1.0, and the x-axis represents time to exit in days from 0 to 130. The LOW group exhibits a faster increase in exit rate than the HIGH group, with a significant log-rank test p-value of 0.0001 indicated on the graph.*
FDA Label Image

150mg Carton Label (90534569 92c7 40dd A902 60e36d3d936c 02)

FDA Label Image

300mg Carton Label (90534569 92c7 40dd A902 60e36d3d936c 01)

FDA Label Image

600mg Carton Label (90534569 92c7 40dd A902 60e36d3d936c 00)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.